David Samuel Silver

David Samuel Silver discloses dealings in Targeted Medical Pharma, Inc. to SEC (Form 4). Over a trading history stretching from 23 February 2012 to 4 March 2016, the count stands at 15 filings.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 7 March 2016, the filings show a share grant worth €26k in Targeted Medical Pharma, Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.